If you have read our 2016 Annual Report (and if you haven’t you should, it’s brilliant) or just seen the cover you’ll know that it features very prominently a young girl named Evie Padilla Vaccaro. Evie was born with Severe Combined Immunodeficiency or SCID – also known as “bubble baby disease”; we’ve written about it … Continue reading CIRM-funded life-saving stem cell therapy gets nod of approval from FDA
Clinical Trials
Why Stem Cell Advocates Texans for Cures say “Right to Try” Legislation Should be Fought
This week in Washington DC a delegation from the stem cell advocacy group Texans for Cures is meeting with members of Congress from both parties. The focus of the meetings are three bills promoting “Right to Try” legislation. Supporters of the bills say they will empower patients battling terminal illness. Texans for Cures say, … Continue reading Why Stem Cell Advocates Texans for Cures say “Right to Try” Legislation Should be Fought
Stem cell agency funds Phase 3 clinical trial for Lou Gehrig’s disease
At CIRM we don’t have a disease hierarchy list that we use to guide where our funding goes. We don’t rank a disease by how many people suffer from it, if it affects children or adults, or how painful it is. But if we did have that kind of hierarchy you can be sure that … Continue reading Stem cell agency funds Phase 3 clinical trial for Lou Gehrig’s disease
‘Pay-to-Participate’ stem cell clinical studies, the ugly stepchild of ClinicalTrials.gov
When patients are looking for clinical trials testing new drugs or treatments for their disease, one of the main websites they visit is ClinicalTrials.gov. It’s a registry provided by the National Institutes of Health (NIH) of approximately 250,000 clinical trials spanning over 200 countries around the world. If you visit the website, you’ll find CIRM’s … Continue reading ‘Pay-to-Participate’ stem cell clinical studies, the ugly stepchild of ClinicalTrials.gov
Novel diabetes therapy uses stem cell “teachers” to calm immune cells
Type 1 diabetes is marked by a loss of insulin-producing beta cells in the pancreas. Without insulin, blood sugar can’t shuttle into the body’s energy-hungry organs and tissues. As a result, sugar accumulates in the blood which, over time, causes many serious complications such as kidney disease, heart disease and stroke. An over-reactive immune system … Continue reading Novel diabetes therapy uses stem cell “teachers” to calm immune cells
Stories that caught our eye: Spinal cord injury trial milestone, iPS for early cancer diagnosis, and storing videos in DNA
Spinal cord injury clinical trial hits another milestone (Kevin McCormack) We began the week with good news about our CIRM-funded clinical trial with Asterias for spinal cord injury, and so it’s nice to end the week with more good news from that same trial. On Wednesday, Asterias announced it had completed enrolling and dosing patients … Continue reading Stories that caught our eye: Spinal cord injury trial milestone, iPS for early cancer diagnosis, and storing videos in DNA
One man’s journey with leukemia has turned into a quest to make bone marrow stem cell transplants safer
I read a story yesterday in Science Magazine that really stuck with me. It’s about a man who was diagnosed with leukemia and received a life-saving stem cell transplant that is now threatening his health. The man is name Lukas Wartman and is a doctor at Washington University School of Medicine in St. Louis. He … Continue reading One man’s journey with leukemia has turned into a quest to make bone marrow stem cell transplants safer
CIRM-funded stem cell clinical trial for spinal cord injury expands patient recruitment
It’s always great to start the week off with some good news. Today we learned that the Food and Drug Administration (FDA) has given Asterias Biotherapeutics approval to expand the number and type of people with spinal cord injuries that it treats in their CIRM-funded clinical trial. Up till now, Asterias has been treating people … Continue reading CIRM-funded stem cell clinical trial for spinal cord injury expands patient recruitment
Wall Street Journal features CIRM-funded clinical trials aiming for a diabetes cure
We think CIRM-funded clinical trials hold so much promise that it doesn’t surprise us when major news organizations publish stories about these projects that aim to provide stem cell treatments to patients with unmet medical needs. But we certainly don’t mind the attention! This past Saturday, for example, the Wall Street Journal featured two CIRM-funded … Continue reading Wall Street Journal features CIRM-funded clinical trials aiming for a diabetes cure
Humacyte Receives Prestigious Technology Pioneer Award for Kidney Failure Treatment
This month, a CIRM-funded company called Humacyte was named one of the World Economic Forum’s 30 Technology Pioneers for 2017. This prestigious award “recognizes early-stage companies from around the world that are involved in the design, development and deployment of new technologies and innovations, and are poised to have a significant impact on business and … Continue reading Humacyte Receives Prestigious Technology Pioneer Award for Kidney Failure Treatment
The Stem Cellar 